Is Infantile Hemangioma a Neuroendocrine Tumor?
Infantile hemangioma (IH) is the most common infantile tumor, affecting 5–10% of newborns. Propranolol, a nonselective β-adrenergic receptor (ADRB) antagonist, is currently the first-line treatment for severe IH; however, both its mechanism of action and its main cellular target remain poorly unders...
Main Authors: | Cario, M. (Author), Gontier, E. (Author), Kaulanjan-Checkmodine, P. (Author), Lacomme, S. (Author), Léauté-Labrèze, C. (Author), Loot, M. (Author), Miljkovic-Licina, M. (Author), Moisan, F. (Author), Oucherif, S. (Author), Prey, S. (Author), Rezvani, H.R (Author), Taieb, A. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Etude du mécanisme d'action du propranolol dans les hémangiomes infantiles
by: Kaulanjan-Checkmodine, Priscilla
Published: (2018) -
Approach to infantile hemangiomas
by: Anil Abraham, et al.
Published: (2016-01-01) -
Hemangioma infantil tratado com propranolol Propranolol treatment for hemangioma of infancy
by: Flavia Kakiuti Bonini, et al.
Published: (2011-08-01) -
New opportunities in the conservative therapy of hemangiomas in children
by: Popova O.A., et al.
Published: (2014-06-01) -
Treatment of infantile hemangioma with propranolol
by: Gian Maria Pacifici